Faster Drug Discovery with NanoTemper Technologies

NanoTemper Technologies develops, manufactures, and markets highly innovative instrument and software solutions for biomolecular analytics. A reputation for excellent products and services has made them the partner of choice for thousands of researchers worldwide, across pharmaceutical, biotechnology, and academic settings.

Booth NTT

Visit booth #1405 and the poster at SLAS to discuss your projects with their Application Specialists. You will learn how to significantly shorten drug discovery and development timelines by employing their unique and proprietary technologies for biophysical characterization of biomolecules.

For example, you can maximize productivity using MicroScale Thermophoresis (MST) by forming rapid and reliable conclusions from your affinity screening data. In formulation development, nanoDSF allows you to predict long-term stability of biopharmaceuticals in only a few hours, using a combination of thermal and chemical unfolding analyses.

In 2016, NanoTemper Technologies launched the novel Monolith His-Tag Labeling Kit. This convenient kit allows site-specific, purification-free labeling of small amounts of His-tagged proteins or peptides, using a simple mix-and-measure approach. Dr. Debora L. Konz Makino (CRELUX GmbH - a WuXi AppTec company) was one of the first MST users to try the kit.

The new labeling method for MST assays allows for a much more practical and quick procedure to fluorescently label any molecule containing a histidine tag,”

“We have applied this method for one of our most challenging targets for biophysical screening. Labeling was quick, easy, and no protein loss or aggregation was observed. […] We are very pleased with this new labeling method […].”

Dr. Debora L. Konz Makino CRELUX GmbH - a WuXi AppTec company.

NanoTemper Technologies has made the Growth Champions 2017 list along with some of Germany’s most successful companies. “Our customers value our high-quality products, and appreciate our service and knowledgeable support. We are successful because our customers are successful”, said Dr. Philipp Baaske, CEO of NanoTemper Technologies, after receiving the award.

Getting curious? NanoTemper Technologies is looking forward to meeting you at booth #1405!


Please use one of the following formats to cite this article in your essay, paper or report:

  • APA

    NanoTemper Technologies. (2019, June 20). Faster Drug Discovery with NanoTemper Technologies. News-Medical. Retrieved on September 30, 2023 from

  • MLA

    NanoTemper Technologies. "Faster Drug Discovery with NanoTemper Technologies". News-Medical. 30 September 2023. <>.

  • Chicago

    NanoTemper Technologies. "Faster Drug Discovery with NanoTemper Technologies". News-Medical. (accessed September 30, 2023).

  • Harvard

    NanoTemper Technologies. 2019. Faster Drug Discovery with NanoTemper Technologies. News-Medical, viewed 30 September 2023,


The opinions expressed here are the views of the writer and do not necessarily reflect the views and opinions of News Medical.
Post a new comment
You might also like...
Unique technology identifies drug candidates, speeds up drug development